GeneDx Holdings Corp (NAS:WGS)
$ 74.86 -0.3 (-0.4%) Market Cap: 2.06 Bil Enterprise Value: 2.06 Bil PE Ratio: 0 PB Ratio: 10.05 GF Score: 43/100

Q4 2022 GeneDx Holdings Corp Earnings Call Transcript

Mar 14, 2023 / 08:30PM GMT
Release Date Price: $11.54 (-3.93%)
Operator

Thank you for standing by, and welcome to GeneDx' Fourth Quarter 2022 Earnings Conference Call. (Operator Instructions) I would now like to hand the call over to Head of Investor Relations, Tricia Truehart. Please go ahead.

Tricia Truehart

Thank you, Latif, and thank you to everyone who is joining us today on this call. I'm Tricia Truehart, Head of Investor Relations at GeneDx. On the call today, we have Katherine Stueland, Chief Executive Officer; and Kevin Feeley, Chief Financial Officer.

Earlier today, GeneDx released financial results for the fourth quarter and full year ended December 31, 2022. A copy of the press release and our fourth quarter earnings slide deck are available on the company's website.

Before we begin, I'd like to remind you that management will make forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot